These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11987817)

  • 1. Junin virus vaccines.
    Enria DA; Barrera Oro JG
    Curr Top Microbiol Immunol; 2002; 263():239-61. PubMed ID: 11987817
    [No Abstract]   [Full Text] [Related]  

  • 2. Genomic features of attenuated Junín virus vaccine strain candidate.
    Goñi SE; Iserte JA; Ambrosio AM; Romanowski V; Ghiringhelli PD; Lozano ME
    Virus Genes; 2006 Feb; 32(1):37-41. PubMed ID: 16525733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Junín virus pathogenesis and virus replication.
    Grant A; Seregin A; Huang C; Kolokoltsova O; Brasier A; Peters C; Paessler S
    Viruses; 2012 Oct; 4(10):2317-39. PubMed ID: 23202466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG subclasses in human immune response to wild and attenuated (vaccine) Junin virus infection.
    del Carmen Saavedra M; Sottosanti JM; Riera L; Ambrosio AM
    J Med Virol; 2003 Mar; 69(3):447-50. PubMed ID: 12526057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination strategies against highly pathogenic arenaviruses: the next steps toward clinical trials.
    Olschläger S; Flatz L
    PLoS Pathog; 2013; 9(4):e1003212. PubMed ID: 23592977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TC83 replicon vectored vaccine provides protection against Junin virus in guinea pigs.
    Seregin AV; Yun NE; Poussard AL; Peng BH; Smith JK; Smith JN; Salazar M; Paessler S
    Vaccine; 2010 Jul; 28(30):4713-8. PubMed ID: 20452431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preclinical assay of candid #1 vaccine against Argentine Hemorrhagic Fever made in Argentina].
    Ambrosio AM; Riera LM; Saavedra Mdel C; Sottosanti MJ
    Medicina (B Aires); 2005; 65(4):329-32. PubMed ID: 16193711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel strategies for development of hemorrhagic fever arenavirus live-attenuated vaccines.
    Martinez-Sobrido L; de la Torre JC
    Expert Rev Vaccines; 2016 Sep; 15(9):1113-21. PubMed ID: 27118328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The major determinant of attenuation in mice of the Candid1 vaccine for Argentine hemorrhagic fever is located in the G2 glycoprotein transmembrane domain.
    Albariño CG; Bird BH; Chakrabarti AK; Dodd KA; Flint M; Bergeron E; White DM; Nichol ST
    J Virol; 2011 Oct; 85(19):10404-8. PubMed ID: 21795336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of live-attenuated arenavirus vaccines based on codon deoptimization.
    Cheng BY; Ortiz-Riaño E; Nogales A; de la Torre JC; Martínez-Sobrido L
    J Virol; 2015 Apr; 89(7):3523-33. PubMed ID: 25589652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The postvaccinal reaction in hamadryas baboons to the administration of attenuated strain 15 of the Venezuelan equine encephalomyelitis virus].
    Filatenkov AG; Khaltaeva GG; Lukin EP; Gorban' SG; Khamitova MF; Shkurnikova NN
    Biull Eksp Biol Med; 1991 Mar; 111(3):287-90. PubMed ID: 2054507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Candid#1 vaccine against Argentine hemorrhagic fever produced in Argentina. Immunogenicity and safety].
    Enria DA; Ambrosio AM; Briggiler AM; Feuillade MR; Crivelli E;
    Medicina (B Aires); 2010; 70(3):215-22. PubMed ID: 20529769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol for the Production of a Vaccine Against Argentinian Hemorrhagic Fever.
    Ambrosio AM; Mariani MA; Maiza AS; Gamboa GS; Fossa SE; Bottale AJ
    Methods Mol Biol; 2018; 1604():305-329. PubMed ID: 28986845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live attenuated vaccines: Historical successes and current challenges.
    Minor PD
    Virology; 2015 May; 479-480():379-92. PubMed ID: 25864107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Japanese encephalitis vaccines.
    Wkly Epidemiol Rec; 1998 Oct; 73(44):337-44. PubMed ID: 9817024
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular analysis of the virulence attenuation process in Junín virus vaccine genealogy.
    Goñi SE; Iserte JA; Stephan BI; Borio CS; Ghiringhelli PD; Lozano ME
    Virus Genes; 2010 Jun; 40(3):320-8. PubMed ID: 20148301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phenotypic markers of attenuation in Junin virus strains recently isolated from individuals vaccinated with Junin Candid#1 strain].
    Gamboa GS; Ambrosio AM; Maiza AS; Mariani M; Rodrigues Garcia Armôa G; Saavedra Mdel C
    Medicina (B Aires); 2013; 73(4):303-9. PubMed ID: 23924527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ectodomain of Glycoprotein from the Candid#1 Vaccine Strain of Junin Virus Rendered Machupo Virus Partially Attenuated in Mice Lacking IFN-αβ/γ Receptor.
    Koma T; Huang C; Aronson JF; Walker AG; Miller M; Smith JN; Patterson M; Paessler S
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004969. PubMed ID: 27580122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epistastic Interactions within the Junín Virus Envelope Glycoprotein Complex Provide an Evolutionary Barrier to Reversion in the Live-Attenuated Candid#1 Vaccine.
    York J; Nunberg JH
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29070682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended Preclinical Safety, Efficacy and Stability Testing of a Live-attenuated Chikungunya Vaccine Candidate.
    Plante KS; Rossi SL; Bergren NA; Seymour RL; Weaver SC
    PLoS Negl Trop Dis; 2015; 9(9):e0004007. PubMed ID: 26340754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.